GlaxoSmithKline Egypt has appointed former general manager Mohamed Eldababy (LinkedIn) as its new CEO and managing director, and former vice president of performance markets Dylan Jackson (LinkedIn) as its new chairman, replacing Ashraf Mansour, Al Borsa reports.